Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alkermes
Biotech
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Sarepta CEO to step down as DM1 hits close to home. Pops descends from Alkermes CEO seat. Former Novartis CMO Tsai saunters to Daiichi.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Feb 27, 2026 8:30am
Midsize biotechs form coalition to fight against MFN policy
Feb 25, 2026 1:05pm
Alkermes races to phase 3 after posting another narcolepsy win
Nov 12, 2025 9:30am
Takeda, Alkermes lift lid on narcolepsy rivals as race heats up
Sep 8, 2025 6:47am
Chasing Takeda, Alkermes reports phase 2 narcolepsy win
Jul 21, 2025 8:40am
Alkermes impresses in full-throttle narcolepsy race with Takeda
Jun 4, 2024 9:01am